david James - chairman
The Scientific Advisory Board for Valitacell is chaired by Prof. David James of the University of Sheffield. David graduated in 1989 from King ́s College London with a Ph.D. in Biochemistry, followed by postdoctoral research in Wye College (University of London), then the University of Kent; the latter a joint project with the Advanced Centre for Biochemical Engineering at University College London. He moved to the University of Queensland in 2001 as an Associate Professor of Bioengineering, then Professorial Research Fellow in the Australian Institute of Bioengineering and Nanotechnology. David was appointed Chair in Bioprocess Engineering at Sheffield in 2006 with a Royal Society Wolfson Research Merit Award "Research and Training in Biopharmaceutical Bioprocessing for UK Bioindustry".
Frank Barry - Scientific Advisor
Prof. Frank Barry is Scientific Director of the Regenerative Medicine Institute (REMEDI) and Director of the National Centre for Biomedical Engineering Science (NCBES) at NUI Galway. He is an internationally renowned stem cell researcher with a particular research interest in the therapeutic application of adult stem cells, especially mesenchymal stem cells (MSCs) from bone marrow. For over 10 years he has directed a series of research programmes focusing on the isolation and characterization of adult stem cells, and on the development of methods for their delivery in a variety of clinical indications. He has also developed approaches for the use of MSCs for the delivery of specific therapeutic genes, for example in rheumatoid arthritis. In addition he has an interest in proteomics and mass spectrometry for the identification of surface molecules on cells.